2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic the...
Saved in:
| Published in | Canadian journal of cardiology Vol. 32; no. 10; pp. 1170 - 1185 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Inc
01.10.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF patients in the context of the various clinical presentations of coronary artery disease; (2) real-life data with non-vitamin K antagonist oral anticoagulants; (3) the use of antidotes for the reversal of non-vitamin K antagonist oral anticoagulants; (4) digoxin as a rate control agent; (5) perioperative anticoagulation management; and (6) AF surgical therapy including the prevention and treatment of AF after cardiac surgery. The recommendations were developed with the same methodology used for the initial 2010 guidelines and the 2012 and 2014 Focused Updates. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards, individual studies and literature were reviewed for quality and bias; the literature review process and evidence tables are included in the Supplementary Material, and on the CCS Web site. The section on concomitant AF and coronary artery disease was developed in collaboration with the CCS Antiplatelet Guidelines Committee. Details of the updated recommendations are presented, along with their background and rationale. This document is linked to an updated summary of all CCS AF Guidelines recommendations, from 2010 to the present 2016 Focused Update. |
|---|---|
| AbstractList | The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF patients in the context of the various clinical presentations of coronary artery disease; (2) real-life data with non-vitamin K antagonist oral anticoagulants; (3) the use of antidotes for the reversal of non-vitamin K antagonist oral anticoagulants; (4) digoxin as a rate control agent; (5) perioperative anticoagulation management; and (6) AF surgical therapy including the prevention and treatment of AF after cardiac surgery. The recommendations were developed with the same methodology used for the initial 2010 guidelines and the 2012 and 2014 Focused Updates. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards, individual studies and literature were reviewed for quality and bias; the literature review process and evidence tables are included in the Supplementary Material, and on the CCS Web site. The section on concomitant AF and coronary artery disease was developed in collaboration with the CCS Antiplatelet Guidelines Committee. Details of the updated recommendations are presented, along with their background and rationale. This document is linked to an updated summary of all CCS AF Guidelines recommendations, from 2010 to the present 2016 Focused Update.
Le comité des lignes directrices sur la fibrillation auriculaire (FA) de la Société canadienne de cardiologie (SCC) procède régulièrement à l’examen des nouvelles données probantes afin de produire des mises à jour portant sur les avancées d’importance clinique dans ce domaine. Cette mise à jour 2016 porte sur 1) la prise en charge du traitement antithrombotique chez les patients atteints de FA en association avec une maladie cardiaque athérosclérotique (MCAS). 2) les données de la vie réelle relatives aux anticoagulants oraux non-vitamine K; 3) les antidotes aux anticoagulants oraux non-vitamine K; 4) la digoxine pour le contrôle de la fréquence; 5) la prise en charge de l’anticoagulothérapie en contexte périopératoire; et 6) le traitement chirurgical de la FA, y compris la prévention et le traitement de la FA après une chirurgie cardiaque. Ces recommandations ont été élaborées à l’aide de la même méthodologie que celle utilisée pour l’établissement des lignes directrices 2010 et des mises à jour 2012 et 2014. Les données probantes de la littérature scientifique ont été évaluées à l’aide de la méthodologie GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). La section portant sur la FA en association avec une MCAS a été rédigée en collaboration avec le comité de la SCC chargé des lignes directrices relatives aux traitements antiplaquettaires. Les plus récentes recommandations sont accompagnées de leur mise en contexte et de leur justification. Cette mise à jour est liée à un résumé de l’ensemble des recommandations des lignes directrices sur la FA de la SCC de 2010 à 2016. The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF patients in the context of the various clinical presentations of coronary artery disease; (2) real-life data with non-vitamin K antagonist oral anticoagulants; (3) the use of antidotes for the reversal of non-vitamin K antagonist oral anticoagulants; (4) digoxin as a rate control agent; (5) perioperative anticoagulation management; and (6) AF surgical therapy including the prevention and treatment of AF after cardiac surgery. The recommendations were developed with the same methodology used for the initial 2010 guidelines and the 2012 and 2014 Focused Updates. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards, individual studies and literature were reviewed for quality and bias; the literature review process and evidence tables are included in the Supplementary Material, and on the CCS Web site. The section on concomitant AF and coronary artery disease was developed in collaboration with the CCS Antiplatelet Guidelines Committee. Details of the updated recommendations are presented, along with their background and rationale. This document is linked to an updated summary of all CCS AF Guidelines recommendations, from 2010 to the present 2016 Focused Update. Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF patients in the context of the various clinical presentations of coronary artery disease; (2) real-life data with non-vitamin K antagonist oral anticoagulants; (3) the use of antidotes for the reversal of non-vitamin K antagonist oral anticoagulants; (4) digoxin as a rate control agent; (5) perioperative anticoagulation management; and (6) AF surgical therapy including the prevention and treatment of AF after cardiac surgery. The recommendations were developed with the same methodology used for the initial 2010 guidelines and the 2012 and 2014 Focused Updates. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards, individual studies and literature were reviewed for quality and bias; the literature review process and evidence tables are included in the Supplementary Material, and on the CCS Web site. The section on concomitant AF and coronary artery disease was developed in collaboration with the CCS Antiplatelet Guidelines Committee. Details of the updated recommendations are presented, along with their background and rationale. This document is linked to an updated summary of all CCS AF Guidelines recommendations, from 2010 to the present 2016 Focused Update. |
| Author | Atzema, Clare, MD Pilote, Louise, MD Mitchell, L. Brent, MD Sharma, Mike, MD Connolly, Stuart, MD Parkash, Ratika, MD Tsang, Teresa, MD Bell, Alan, MD Cox, Jafna L., MD Healey, Jeff S., MD Skanes, Allan, MD Gladstone, David, MD Talajic, Mario, MD Macle, Laurent, MD Cairns, John, MD Andrade, Jason G., MD Verma, Atul, MD Leblanc, Kori, PharmD Dorian, Paul, MD Verma, Subodh, MD Nattel, Stanley, MD |
| Author_xml | – sequence: 1 fullname: Macle, Laurent, MD – sequence: 2 fullname: Cairns, John, MD – sequence: 3 fullname: Leblanc, Kori, PharmD – sequence: 4 fullname: Tsang, Teresa, MD – sequence: 5 fullname: Skanes, Allan, MD – sequence: 6 fullname: Cox, Jafna L., MD – sequence: 7 fullname: Healey, Jeff S., MD – sequence: 8 fullname: Bell, Alan, MD – sequence: 9 fullname: Pilote, Louise, MD – sequence: 10 fullname: Andrade, Jason G., MD – sequence: 11 fullname: Mitchell, L. Brent, MD – sequence: 12 fullname: Atzema, Clare, MD – sequence: 13 fullname: Gladstone, David, MD – sequence: 14 fullname: Sharma, Mike, MD – sequence: 15 fullname: Verma, Subodh, MD – sequence: 16 fullname: Connolly, Stuart, MD – sequence: 17 fullname: Dorian, Paul, MD – sequence: 18 fullname: Parkash, Ratika, MD – sequence: 19 fullname: Talajic, Mario, MD – sequence: 20 fullname: Nattel, Stanley, MD – sequence: 21 fullname: Verma, Atul, MD |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27609430$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc1u1DAURi1URKeFF2CBsmST1HYS_0gIqRoxBamIRanEznLsG3DI2IPtVJq3x2EKiy5Y-S6-8-n63At05oMHhF4T3BBM2NXUmMnohpa5wbzpJXmGNkQSVnPM-zO0wYKKmgr67RxdpDRh3BHO2Qt0TjnDsmvxBoWVrnbBLAlsdX-wOkMVxir_gGqrvbZO-zJE68KDTmaZdazugnGQj9XN4izMzkOqxhD_IJ8L8h324PNacp2j03O1c0N086yzC_4lej7qOcGrx_cS3e8-fN1-rG-_3HzaXt_Wpqck11ZSw_XQQmsGRgZhAQs59AxjYjqhu85Ya7rRjl0vZUeE5rqAZsCcScwIbS_R21PvIYZfC6Ss9i4ZKFt4CEtSRLR9KyjvcYnSU9TEkFKEUR2i2-t4VASrVbSa1CparaoU5qqILtCbx_5l2IP9h_w1WwLvTgEov3xwEFUq1rwB6yKYrGxw_-9__wQ3xbQzev4JR0hTWKIv_hRRiSqs7tZTr5cmrC2j5O1vOISlog |
| CitedBy_id | crossref_primary_10_1024_0301_1526_a000789 crossref_primary_10_1007_s00228_017_2337_9 crossref_primary_10_1016_j_artere_2019_11_003 crossref_primary_10_1111_jce_13138 crossref_primary_10_1016_j_ahj_2018_06_005 crossref_primary_10_1016_j_ahj_2017_12_007 crossref_primary_10_1016_j_cjco_2019_05_007 crossref_primary_10_1016_j_annemergmed_2022_03_010 crossref_primary_10_1007_s13318_018_0501_y crossref_primary_10_1093_eurheartj_suaa176 crossref_primary_10_1016_j_cjca_2018_07_010 crossref_primary_10_1002_clc_23316 crossref_primary_10_1007_s11886_020_01390_2 crossref_primary_10_1016_j_cjca_2018_07_014 crossref_primary_10_1007_s43678_021_00243_3 crossref_primary_10_1136_ejhpharm_2018_001520 crossref_primary_10_1097_NCQ_0000000000000381 crossref_primary_10_1161_JAHA_118_009391 crossref_primary_10_1097_MD_0000000000011549 crossref_primary_10_1016_j_trre_2018_04_002 crossref_primary_10_1007_s12325_017_0616_6 crossref_primary_10_1016_j_cjca_2017_09_014 crossref_primary_10_1080_14779072_2018_1475229 crossref_primary_10_1177_2048872618801763 crossref_primary_10_1080_14779072_2018_1490644 crossref_primary_10_1016_j_cjca_2018_08_035 crossref_primary_10_1007_s40620_019_00592_4 crossref_primary_10_1002_joa3_13051 crossref_primary_10_1093_eurheartj_ehy731 crossref_primary_10_3389_fphys_2018_00876 crossref_primary_10_3390_jcm12134534 crossref_primary_10_1186_s12872_018_0915_0 crossref_primary_10_1016_j_cjca_2017_10_003 crossref_primary_10_1016_j_cjca_2018_07_476 crossref_primary_10_1016_j_cjca_2018_08_026 crossref_primary_10_1016_j_thromres_2018_11_015 crossref_primary_10_1253_circj_CJ_20_1212 crossref_primary_10_1053_j_jvca_2020_02_038 crossref_primary_10_1093_europace_euy310 crossref_primary_10_1016_j_cjca_2018_08_028 crossref_primary_10_1038_s41569_020_00459_3 crossref_primary_10_1016_j_jacc_2018_03_519 crossref_primary_10_1007_s40140_019_00321_4 crossref_primary_10_1016_j_cjca_2017_10_012 crossref_primary_10_1016_j_ccep_2020_11_011 crossref_primary_10_1097_ANA_0000000000000686 crossref_primary_10_1016_j_jacep_2018_02_006 crossref_primary_10_1177_2054358117735532 crossref_primary_10_1007_s43678_023_00462_w crossref_primary_10_1016_j_amjmed_2017_02_026 crossref_primary_10_1155_2019_4525084 crossref_primary_10_1093_eurheartj_ehz521 crossref_primary_10_1016_j_ahj_2023_01_004 crossref_primary_10_1016_j_cjca_2017_06_001 crossref_primary_10_1016_j_cjca_2017_06_002 crossref_primary_10_1016_j_cjca_2019_06_006 crossref_primary_10_1016_j_amjcard_2017_05_027 crossref_primary_10_4997_jrcpe_2017_105 crossref_primary_10_1111_jth_15195 crossref_primary_10_1002_clc_22936 crossref_primary_10_1002_joa3_12095 crossref_primary_10_1007_s10557_018_6789_7 crossref_primary_10_1515_dx_2018_0001 crossref_primary_10_1016_j_cjca_2017_08_022 crossref_primary_10_1001_jamainternmed_2020_1835 crossref_primary_10_15212_CVIA_2016_0060 crossref_primary_10_7759_cureus_27838 crossref_primary_10_1111_pace_14091 crossref_primary_10_1007_s11739_019_02169_2 crossref_primary_10_1111_ijcp_13625 crossref_primary_10_3390_jcm12206559 crossref_primary_10_1016_j_cjca_2019_02_009 crossref_primary_10_1002_pds_5317 crossref_primary_10_1007_s00392_018_1368_2 crossref_primary_10_1111_ijcp_13280 crossref_primary_10_1016_j_cjca_2018_04_019 crossref_primary_10_3138_jammi_2018_0038 crossref_primary_10_1016_j_cjco_2019_06_002 crossref_primary_10_1161_CIRCEP_118_006498 crossref_primary_10_1016_j_cjca_2017_07_479 crossref_primary_10_3389_fcvm_2020_615065 crossref_primary_10_1111_bcp_15046 crossref_primary_10_1016_j_cjca_2018_11_023 crossref_primary_10_16919_bozoktip_364971 crossref_primary_10_1016_j_jacc_2017_06_033 crossref_primary_10_1080_14779072_2018_1496018 crossref_primary_10_1016_j_jacep_2017_08_003 crossref_primary_10_1016_j_cjco_2021_11_002 crossref_primary_10_1007_s10557_019_06869_x crossref_primary_10_1007_s00520_019_04816_y crossref_primary_10_1080_14779072_2018_1521721 crossref_primary_10_1053_j_ajkd_2017_08_003 crossref_primary_10_1161_CIRCOUTCOMES_118_004580 crossref_primary_10_1007_s10557_017_6730_5 crossref_primary_10_1016_j_apmr_2018_04_023 crossref_primary_10_1111_aas_13507 crossref_primary_10_2174_1874220301906010033 crossref_primary_10_1016_S1636_5410_18_91426_1 crossref_primary_10_1007_s10557_018_6795_9 crossref_primary_10_1007_s40256_018_0292_1 crossref_primary_10_1111_acem_14618 crossref_primary_10_7326_M19_2522 crossref_primary_10_1002_clc_23035 crossref_primary_10_7326_ACPJ201906180_071 crossref_primary_10_1161_CIRCINTERVENTIONS_116_004395 crossref_primary_10_1160_TH16_11_0876 crossref_primary_10_2174_1570161116666180101150956 crossref_primary_10_1007_s11239_021_02530_3 crossref_primary_10_1007_s43441_019_00001_9 crossref_primary_10_1016_j_ahj_2018_04_008 crossref_primary_10_1016_j_cjca_2019_03_001 crossref_primary_10_1213_ANE_0000000000004959 crossref_primary_10_1016_j_cjco_2021_04_002 crossref_primary_10_1177_1715163520909137 crossref_primary_10_1016_j_cjca_2016_10_007 crossref_primary_10_1093_ndt_gfy031 crossref_primary_10_1253_circj_CJ_19_0546 crossref_primary_10_1186_s12874_020_00953_9 crossref_primary_10_9778_cmajo_20200138 crossref_primary_10_1002_clc_23053 crossref_primary_10_1016_j_ijcard_2017_10_091 crossref_primary_10_3390_medicina58010045 crossref_primary_10_1016_j_ajem_2018_01_066 crossref_primary_10_1016_j_cjca_2017_12_012 crossref_primary_10_1007_s00464_020_07604_6 crossref_primary_10_2217_fca_2018_0010 crossref_primary_10_1007_s11255_018_1877_y crossref_primary_10_1016_j_cjca_2017_12_008 crossref_primary_10_1016_j_ahj_2017_11_004 crossref_primary_10_1007_s40266_017_0476_4 crossref_primary_10_1097_JCMA_0000000000000050 crossref_primary_10_1016_j_athoracsur_2020_05_104 crossref_primary_10_1371_journal_pmed_1002903 crossref_primary_10_1016_j_cjco_2021_12_007 crossref_primary_10_1253_circj_CJ_17_1058 crossref_primary_10_1016_j_cjca_2019_08_040 crossref_primary_10_1111_acem_13410 crossref_primary_10_1016_j_ijcard_2019_04_066 crossref_primary_10_1097_ALN_0000000000003664 crossref_primary_10_1177_1747493018790029 crossref_primary_10_1097_01_NPR_0000681780_47800_a3 crossref_primary_10_1016_j_cjca_2020_10_001 crossref_primary_10_1016_j_jaad_2020_10_008 crossref_primary_10_1007_s43678_021_00167_y crossref_primary_10_1016_j_jdmv_2020_04_002 crossref_primary_10_1097_MD_0000000000010822 crossref_primary_10_1097_MD_0000000000010390 crossref_primary_10_1161_STROKEAHA_119_025169 crossref_primary_10_1111_jocs_14989 crossref_primary_10_1038_s41598_018_33531_7 crossref_primary_10_1161_JAHA_122_028396 crossref_primary_10_1155_2019_6419147 crossref_primary_10_3389_fcvm_2022_803233 crossref_primary_10_1016_j_jsha_2017_05_001 crossref_primary_10_1016_j_cjco_2022_10_004 crossref_primary_10_1016_j_jclinepi_2020_05_031 crossref_primary_10_1007_s00059_017_4648_0 crossref_primary_10_1016_j_atherosclerosis_2019_08_021 crossref_primary_10_1016_j_cjca_2017_04_008 crossref_primary_10_1016_j_cjca_2021_06_016 crossref_primary_10_1016_j_cjca_2017_11_022 crossref_primary_10_1007_s12471_023_01849_1 crossref_primary_10_1093_eurheartj_suw049 crossref_primary_10_1002_clc_22898 crossref_primary_10_1016_j_ijcard_2020_10_075 crossref_primary_10_1016_j_ijcard_2017_06_110 crossref_primary_10_1089_trgh_2023_0172 crossref_primary_10_1016_j_cjca_2018_02_010 crossref_primary_10_1136_bmjebm_2018_111098 crossref_primary_10_1016_j_amjcard_2023_08_004 crossref_primary_10_1016_j_cjca_2018_02_016 crossref_primary_10_12677_ACM_2022_1212656 crossref_primary_10_1016_j_cjca_2017_05_022 crossref_primary_10_18553_jmcp_2018_24_4_357 crossref_primary_10_1111_evj_13518 crossref_primary_10_12677_ACM_2022_122175 crossref_primary_10_1016_j_cjca_2020_09_001 crossref_primary_10_1016_j_arteri_2019_01_006 crossref_primary_10_1016_j_ccl_2017_08_008 crossref_primary_10_1017_cem_2018_415 crossref_primary_10_18621_eurj_1038532 crossref_primary_10_1111_jocs_14194 crossref_primary_10_1016_j_cjca_2019_04_022 crossref_primary_10_1055_s_0040_1719081 crossref_primary_10_1002_joa3_12714 crossref_primary_10_1016_j_cjca_2017_11_009 crossref_primary_10_1097_MNH_0000000000000410 crossref_primary_10_1016_j_amjcard_2019_02_003 crossref_primary_10_1017_cem_2018_26 crossref_primary_10_1016_j_cjco_2020_12_025 crossref_primary_10_1016_j_jacep_2018_03_001 crossref_primary_10_3389_fcvm_2023_1156626 crossref_primary_10_1016_j_jemermed_2018_12_010 crossref_primary_10_1177_1715163518756926 |
| Cites_doi | 10.1001/jama.2012.14144 10.1378/chest.11-2298 10.1161/CIRCULATIONAHA.112.115386 10.1016/j.jacc.2015.03.003 10.4103/0253-7613.144905 10.1016/j.amjcard.2015.02.003 10.1056/NEJMoa1310907 10.1016/S0140-6736(15)00273-1 10.1016/j.cjca.2012.01.021 10.1016/j.cjca.2013.07.001 10.1016/0003-4975(95)00887-X 10.1056/NEJMoa1009638 10.1016/S0140-6736(09)61343-X 10.1016/j.hrthm.2015.08.028 10.1136/ebmed-2015-110263 10.1016/S0735-1097(02)02776-6 10.1056/NEJMoa1501035 10.1161/CIRCULATIONAHA.115.015688 10.1093/eurheartj/ehn333 10.1160/TH14-12-1080 10.1016/0002-9149(79)90456-9 10.1016/j.jacc.2015.04.025 10.1186/s12878-015-0039-z 10.1016/j.cjca.2010.11.008 10.1056/NEJMoa0706482 10.1067/mtc.2002.124392 10.1016/j.ahj.2015.12.007 10.1016/j.jacc.2015.02.050 10.1161/CIRCOUTCOMES.114.001398 10.1056/NEJMoa1302946 10.1001/archneur.65.10.1320 10.1161/STROKEAHA.112.652065 10.1016/j.cjca.2015.06.005 10.1016/j.cjca.2013.04.006 10.1160/TH09-11-0758 10.1016/j.cjca.2010.12.015 10.1160/TH11-04-0262 10.1016/S0140-6736(14)61836-5 10.1161/CIRCULATIONAHA.111.055970 10.1016/j.ejcts.2006.03.028 10.1136/heartjnl-2013-305351 10.1056/NEJMoa1507750 10.1016/S0140-6736(15)60263-X 10.1056/NEJMoa1409312 10.1016/j.jacc.2014.11.053 10.1093/europace/eut083 10.1016/S0140-6736(12)62177-1 10.1016/S0735-1097(98)00561-0 10.1016/j.cjca.2010.11.007 10.1016/S0140-6736(15)60732-2 10.1056/NEJMoa1510991 10.1378/chest.114.5_Supplement.611S 10.1056/NEJMoa1107039 10.1016/j.cjca.2013.06.015 10.1161/CIRCULATIONAHA.111.090464 10.1185/03007995.2014.907140 10.1016/j.amjcard.2014.05.013 10.1378/chest.11-2304 10.1136/bmj.g6427 10.1161/CIRCULATIONAHA.112.105221 10.1093/europace/euv309 10.1186/s12872-015-0068-3 10.1016/j.cjca.2010.11.003 10.1093/eurheartj/ehs290 10.1093/eurheartj/eht557 10.1056/NEJMoa1112277 10.1161/hc0502.103329 10.1056/NEJMoa1602002 10.1016/j.jacc.2015.05.062 10.1160/TH11-01-0052 10.1056/NEJMoa020496 10.1002/clc.22373 10.1136/bmjopen-2012-001592 10.1056/NEJM199007193230302 10.1056/NEJMoa1502000 10.1056/NEJMoa1500857 10.1016/j.cjca.2010.11.005 10.1016/j.cjca.2014.08.001 10.1182/blood-2014-08-595496 10.1093/eurheartj/ehu298 10.1161/CIRCULATIONAHA.114.012061 10.1056/NEJMoa0905561 10.1016/j.cjca.2010.11.001 10.1016/j.jacc.2014.04.029 10.1016/S0140-6736(01)05701-4 10.1056/NEJMoa0904327 10.1161/CIRCULATIONAHA.112.115410 10.1161/CIRCULATIONAHA.115.019628 10.1056/NEJMoa1500528 10.1111/jth.12949 10.1001/jama.2012.28733 10.1160/TH15-03-0247 10.1016/S0022-5223(99)70052-8 10.1056/NEJM199705223362107 10.1016/j.jtcvs.2013.03.015 10.7326/0003-4819-151-5-200909010-00003 10.1016/S0022-5223(03)00550-6 10.1007/s11239-015-1297-0 10.1161/CIRCULATIONAHA.113.005754 10.1016/j.jacc.2014.03.060 10.1056/NEJMoa0901301 10.1136/bmj.h1618 10.1016/S0140-6736(13)62343-0 |
| ContentType | Journal Article |
| Copyright | 2016 Copyright © 2016. Published by Elsevier Inc. |
| Copyright_xml | – notice: 2016 – notice: Copyright © 2016. Published by Elsevier Inc. |
| CorporateAuthor | CCS Atrial Fibrillation Guidelines Committee |
| CorporateAuthor_xml | – name: CCS Atrial Fibrillation Guidelines Committee |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.cjca.2016.07.591 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1916-7075 |
| EndPage | 1185 |
| ExternalDocumentID | 10_1016_j_cjca_2016_07_591 27609430 S0828282X16308297 1_s2_0_S0828282X16308297 |
| Genre | Journal Article Practice Guideline Review |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1P~ 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABXDB ACDAQ ACGFO ACJTP ACRLP ADBBV ADEZE ADMUD ADVLN AEBSH AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXBA AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV E3Z EBS EFJIC EJD F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HX~ HYE HZ~ J1W KOM M41 MO0 O-L O9- OAUVE OA~ OK1 OL0 P-8 P-9 P2P PC. Q38 ROL RPM SDF SEL SES SJN SNG SPCBC SSH SSZ T5K TR2 Z5R ~G- AAIAV ABLVK ABYKQ AISVY AJBFU EFLBG LCYCR NAHTW CGR CUY CVF ECM EIF NPM AAYXX ACRPL ADNMO CITATION 7X8 |
| ID | FETCH-LOGICAL-c521t-d92c7ab3e3cb61b8de089b56001c48a44cddc4fdf4599418a7ac52cb076906123 |
| IEDL.DBID | .~1 |
| ISSN | 0828-282X |
| IngestDate | Fri Oct 25 06:21:25 EDT 2024 Fri Dec 06 03:40:27 EST 2024 Sat Sep 28 08:46:57 EDT 2024 Fri Feb 23 02:12:53 EST 2024 Tue Oct 15 22:57:03 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| License | Copyright © 2016. Published by Elsevier Inc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c521t-d92c7ab3e3cb61b8de089b56001c48a44cddc4fdf4599418a7ac52cb076906123 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Instructional Material/Guideline-3 ObjectType-Feature-4 content type line 23 ObjectType-Review-1 |
| OpenAccessLink | http://www.onlinecjc.ca/article/S0828282X16308297/pdf |
| PMID | 27609430 |
| PQID | 1835382750 |
| PQPubID | 23479 |
| PageCount | 16 |
| ParticipantIDs | proquest_miscellaneous_1835382750 crossref_primary_10_1016_j_cjca_2016_07_591 pubmed_primary_27609430 elsevier_sciencedirect_doi_10_1016_j_cjca_2016_07_591 elsevier_clinicalkeyesjournals_1_s2_0_S0828282X16308297 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-10-01 |
| PublicationDateYYYYMMDD | 2016-10-01 |
| PublicationDate_xml | – month: 10 year: 2016 text: 2016-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Canadian journal of cardiology |
| PublicationTitleAlternate | Can J Cardiol |
| PublicationYear | 2016 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Essebag, Healey, Ayala-Paredes (bib70) 2016; 173 Pollack, Reilly, Eikelboom (bib64) 2015; 373 Macle, Cairns, Andrade (bib5) 2015; 31 Dentali, Marchesi, Giorgi Pierfranceschi (bib57) 2011; 106 Connolly, Ezekowitz, Yusuf (bib19) 2009; 361 Bonaca, Bhatt, Cohen (bib39) 2015; 372 Avgil-Tsadok, Jackevicius, Essebag (bib46) 2016; 115 Douketis, Spyropoulos, Spencer (bib67) 2012; 141 Bando, Kobayashi, Hirata (bib90) 2003; 126 Lip, Windecker, Huber (bib9) 2014; 35 Verma, Eikelboom, Nidorf (bib111) 2015; 15 Fiedler, Maeng, Mehilli (bib42) 2015; 65 D'Ascenzo, Taha, Moretti (bib34) 2015; 115 Douketis, Spyropoulos, Kaatz (bib72) 2015; 373 Zhang, Zhen, Tao, Bao, Zhang (bib107) 2014; 63 Heidbuchel, Verhamme, Alings (bib10) 2015; 17 Mega, Braunwald, Wiviott (bib43) 2012; 366 Whitlock, Devereaux, Teoh (bib106) 2015; 386 Sherwood, Douketis, Patel (bib74) 2014; 129 Itoh, Kobayashi, Bando (bib91) 2006; 29 Cairns, Connolly, McMurtry (bib4) 2011; 27 Glund, Moschetti, Norris (bib62) 2015; 113 Patel, Mahaffey, Garg (bib24) 2011; 365 Costanzo, di Niro, Di Castelnuovo (bib108) 2013; 146 Dieleman, Nierich, Rosseel (bib105) 2012; 308 You, Singer, Howard (bib18) 2012; 141 Arsenault, Yusuf, Crystal (bib102) 2013; 1 Yeh, Kereiakes, Steg (bib32) 2015; 65 Holmes, Reddy, Turi (bib94) 2009; 374 Bell, Roussin, Cartier (bib6) 2011; 27 Washam, Stevens, Lokhnygina (bib82) 2015; 385 Zubkov, Mandrekar, Claassen (bib52) 2008; 65 Hurlen, Abdelnoor, Smith, Erikssen, Arnesen (bib15) 2002; 347 Kearon, Hirsh (bib66) 1997; 336 Gillis, Skanes (bib1) 2011; 27 Mitchell (bib100) 2011; 27 Smith, Arnesen, Holme (bib14) 1990; 323 Ruff, Giugliano, Braunwald (bib26) 2014; 383 Holmes, Kar, Price (bib95) 2014; 64 Heidbuchel, Verhamme, Alings (bib53) 2013; 15 Trivedi, Sadadia (bib110) 2014; 46 Valgimigli, Sabate, Kaiser (bib30) 2014; 349 Whitlock, Vincent, Blackall (bib97) 2013; 29 Cairns, McMurtry (bib12) 2013; 29 Whitlock, Healey, Vincent (bib98) 2014; 3 U.S. Food and Drug Administration. FDA drug safety communication: safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate). Available at Tanguay, Bell, Ackman (bib7) 2013; 29 Dewilde, Oirbans, Verheugt (bib35) 2013; 381 Wallentin, Becker, Budaj (bib38) 2009; 361 Palmerini, Benedetto, Bacchi-Reggiani (bib29) 2015; 385 Verma, Cairns, Mitchell (bib3) 2014; 30 Accessed May 10, 2016. Mak (bib21) 2012; 2 Glund, Stangier, Schmohl (bib63) 2015; 386 Granger, Alexander, McMurray (bib23) 2011; 365 Anand, Yusuf (bib17) 2003; 41 Dzik (bib56) 2015; 13 Turakhia, Santangeli, Winkelmayer (bib81) 2014; 64 Laliberte, Cloutier, Nelson (bib49) 2014; 30 Aronis, Hylek (bib55) 2016; 41 Shah, Avgil Tsadok, Jackevicius (bib83) 2014; 114 Fiore, Ezekowitz, Brophy (bib16) 2002; 105 Glund S, Stangier J, Schmohl M, et al. Idarucizumab, a specific antidote for dabigatran: immediate, complete and sustained reversal of dabigatran induced anticoagulation in elderly and renally impaired subjects. Available at Cairns, Theroux, Lewis (bib13) 1998; 114 The ACTIVE Investigators, Connolly, Pogue (bib40) 2009; 360 Faxon, Eikelboom, Berger (bib11) 2011; 106 Gillinov, Gelijns, Parides (bib88) 2015; 372 Valgimigli, Patialiakas, Thury (bib31) 2015; 65 Budera, Straka, Osmancik (bib87) 2012; 33 Bando, Kobayashi, Kosakai (bib89) 2002; 124 Hess, Peterson, Peng (bib33) 2015; 66 Accessed May 10, 2016. Avgil Tsadok, Jackevicius, Rahme, Humphries, Pilote (bib50) 2015; 8 Garcia, Alexander, Wallentin (bib75) 2014; 124 Schulman, Carrier, Lee (bib77) 2015; 132 Zheng, Jayaram, Jiang (bib103) 2016; 374 Graham, Reichman, Wernecke (bib44) 2015; 131 Dowlatshahi, Butcher, Asdaghi (bib51) 2012; 43 Mehta, Yusuf, Peters (bib36) 2001; 358 Gillinov, Bagiella, Moskowitz (bib101) 2016; 374 Thrombosis Canada. Tools. Bleed Management. Available at Blackshear, Odell (bib93) 1996; 61 Giugliano, Ruff, Braunwald (bib25) 2013; 369 Hohnloser, Oldgren, Yang (bib20) 2012; 125 Healey, Eikelboom, Douketis (bib73) 2012; 126 Beyer-Westendorf, Gelbricht, Forster (bib78) 2014; 35 Page (bib99) 2011; 27 Singer, Chang, Fang (bib8) 2009; 151 Sholzberg, Pavenski, Shehata, Cserti-Gazdewich, Lin (bib58) 2015; 15 Gillis, Verma, Talajic (bib85) 2011; 27 Dentali, Riva, Crowther (bib22) 2012; 126 Thrombosis Canada. Peri-operative management of patients who are receiving warfarin. Available at Whitlock, Chan, Devereaux (bib104) 2008; 29 Andrade, Roy, Wyse (bib84) 2016; 13 David, Segni, Klein, Kaplinsky (bib80) 1979; 44 Siegal, Curnutte, Connolly (bib59) 2015; 373 Dans, Connolly, Wallentin (bib41) 2013; 127 Siegal, Yudin, Kaatz (bib71) 2012; 126 Mauri, Kereiakes, Yeh (bib27) 2014; 371 Birnie, Healey, Wells (bib69) 2013; 368 Mozaffarian, Marchioli, Macchia (bib109) 2012; 308 Cox, Ad, Palazzo (bib92) 1999; 118 Farshi, Kistner, Sarma, Longmate, Singh (bib79) 1999; 33 Phan, Xie, La Meir, Black, Yan (bib86) 2014; 100 van Ryn, Stangier, Haertter (bib65) 2010; 103 Skanes, Healey, Cairns (bib2) 2012; 28 Steinberg (bib76) 2015; 20 Navarese, Andreotti, Schulze (bib28) 2015; 350 Tamayo, Frank Peacock, Patel (bib48) 2015; 38 Holmes, Doshi, Kar (bib96) 2015; 65 Lauffenburger, Farley, Gehi (bib47) 2015; 4 Wiviott, Braunwald, McCabe (bib37) 2007; 357 Eikelboom, Quinlan, van Ryn, Weitz (bib60) 2015; 132 28153579 - Can J Cardiol. 2017 Apr;33(4):552-553 Sherwood (10.1016/j.cjca.2016.07.591_bib74) 2014; 129 Mehta (10.1016/j.cjca.2016.07.591_bib36) 2001; 358 Fiedler (10.1016/j.cjca.2016.07.591_bib42) 2015; 65 Graham (10.1016/j.cjca.2016.07.591_bib44) 2015; 131 D'Ascenzo (10.1016/j.cjca.2016.07.591_bib34) 2015; 115 10.1016/j.cjca.2016.07.591_bib54 Gillis (10.1016/j.cjca.2016.07.591_bib1) 2011; 27 Healey (10.1016/j.cjca.2016.07.591_bib73) 2012; 126 Cairns (10.1016/j.cjca.2016.07.591_bib4) 2011; 27 Zubkov (10.1016/j.cjca.2016.07.591_bib52) 2008; 65 Dowlatshahi (10.1016/j.cjca.2016.07.591_bib51) 2012; 43 Granger (10.1016/j.cjca.2016.07.591_bib23) 2011; 365 Wiviott (10.1016/j.cjca.2016.07.591_bib37) 2007; 357 Whitlock (10.1016/j.cjca.2016.07.591_bib98) 2014; 3 10.1016/j.cjca.2016.07.591_bib61 Connolly (10.1016/j.cjca.2016.07.591_bib19) 2009; 361 Giugliano (10.1016/j.cjca.2016.07.591_bib25) 2013; 369 Douketis (10.1016/j.cjca.2016.07.591_bib72) 2015; 373 10.1016/j.cjca.2016.07.591_bib45 Cairns (10.1016/j.cjca.2016.07.591_bib12) 2013; 29 Zhang (10.1016/j.cjca.2016.07.591_bib107) 2014; 63 Mauri (10.1016/j.cjca.2016.07.591_bib27) 2014; 371 Bando (10.1016/j.cjca.2016.07.591_bib90) 2003; 126 Faxon (10.1016/j.cjca.2016.07.591_bib11) 2011; 106 Dieleman (10.1016/j.cjca.2016.07.591_bib105) 2012; 308 Phan (10.1016/j.cjca.2016.07.591_bib86) 2014; 100 Turakhia (10.1016/j.cjca.2016.07.591_bib81) 2014; 64 Wallentin (10.1016/j.cjca.2016.07.591_bib38) 2009; 361 Page (10.1016/j.cjca.2016.07.591_bib99) 2011; 27 Ruff (10.1016/j.cjca.2016.07.591_bib26) 2014; 383 Budera (10.1016/j.cjca.2016.07.591_bib87) 2012; 33 Heidbuchel (10.1016/j.cjca.2016.07.591_bib53) 2013; 15 Laliberte (10.1016/j.cjca.2016.07.591_bib49) 2014; 30 Garcia (10.1016/j.cjca.2016.07.591_bib75) 2014; 124 Zheng (10.1016/j.cjca.2016.07.591_bib103) 2016; 374 Washam (10.1016/j.cjca.2016.07.591_bib82) 2015; 385 Hohnloser (10.1016/j.cjca.2016.07.591_bib20) 2012; 125 Dans (10.1016/j.cjca.2016.07.591_bib41) 2013; 127 Sholzberg (10.1016/j.cjca.2016.07.591_bib58) 2015; 15 Mak (10.1016/j.cjca.2016.07.591_bib21) 2012; 2 Douketis (10.1016/j.cjca.2016.07.591_bib67) 2012; 141 Bonaca (10.1016/j.cjca.2016.07.591_bib39) 2015; 372 Schulman (10.1016/j.cjca.2016.07.591_bib77) 2015; 132 Steinberg (10.1016/j.cjca.2016.07.591_bib76) 2015; 20 Lauffenburger (10.1016/j.cjca.2016.07.591_bib47) 2015; 4 Glund (10.1016/j.cjca.2016.07.591_bib62) 2015; 113 Valgimigli (10.1016/j.cjca.2016.07.591_bib31) 2015; 65 10.1016/j.cjca.2016.07.591_bib68 Yeh (10.1016/j.cjca.2016.07.591_bib32) 2015; 65 Essebag (10.1016/j.cjca.2016.07.591_bib70) 2016; 173 Skanes (10.1016/j.cjca.2016.07.591_bib2) 2012; 28 Dzik (10.1016/j.cjca.2016.07.591_bib56) 2015; 13 Singer (10.1016/j.cjca.2016.07.591_bib8) 2009; 151 Siegal (10.1016/j.cjca.2016.07.591_bib59) 2015; 373 Holmes (10.1016/j.cjca.2016.07.591_bib96) 2015; 65 Andrade (10.1016/j.cjca.2016.07.591_bib84) 2016; 13 van Ryn (10.1016/j.cjca.2016.07.591_bib65) 2010; 103 Mitchell (10.1016/j.cjca.2016.07.591_bib100) 2011; 27 Pollack (10.1016/j.cjca.2016.07.591_bib64) 2015; 373 Palmerini (10.1016/j.cjca.2016.07.591_bib29) 2015; 385 Verma (10.1016/j.cjca.2016.07.591_bib3) 2014; 30 Blackshear (10.1016/j.cjca.2016.07.591_bib93) 1996; 61 Mega (10.1016/j.cjca.2016.07.591_bib43) 2012; 366 Dewilde (10.1016/j.cjca.2016.07.591_bib35) 2013; 381 Itoh (10.1016/j.cjca.2016.07.591_bib91) 2006; 29 Farshi (10.1016/j.cjca.2016.07.591_bib79) 1999; 33 Gillinov (10.1016/j.cjca.2016.07.591_bib101) 2016; 374 Heidbuchel (10.1016/j.cjca.2016.07.591_bib10) 2015; 17 Arsenault (10.1016/j.cjca.2016.07.591_bib102) 2013; 1 Avgil-Tsadok (10.1016/j.cjca.2016.07.591_bib46) 2016; 115 Holmes (10.1016/j.cjca.2016.07.591_bib95) 2014; 64 Bell (10.1016/j.cjca.2016.07.591_bib6) 2011; 27 Navarese (10.1016/j.cjca.2016.07.591_bib28) 2015; 350 Aronis (10.1016/j.cjca.2016.07.591_bib55) 2016; 41 Hurlen (10.1016/j.cjca.2016.07.591_bib15) 2002; 347 You (10.1016/j.cjca.2016.07.591_bib18) 2012; 141 Birnie (10.1016/j.cjca.2016.07.591_bib69) 2013; 368 The ACTIVE Investigators (10.1016/j.cjca.2016.07.591_bib40) 2009; 360 Kearon (10.1016/j.cjca.2016.07.591_bib66) 1997; 336 Whitlock (10.1016/j.cjca.2016.07.591_bib97) 2013; 29 Whitlock (10.1016/j.cjca.2016.07.591_bib106) 2015; 386 Macle (10.1016/j.cjca.2016.07.591_bib5) 2015; 31 Holmes (10.1016/j.cjca.2016.07.591_bib94) 2009; 374 Valgimigli (10.1016/j.cjca.2016.07.591_bib30) 2014; 349 Hess (10.1016/j.cjca.2016.07.591_bib33) 2015; 66 Gillis (10.1016/j.cjca.2016.07.591_bib85) 2011; 27 Shah (10.1016/j.cjca.2016.07.591_bib83) 2014; 114 Lip (10.1016/j.cjca.2016.07.591_bib9) 2014; 35 Dentali (10.1016/j.cjca.2016.07.591_bib57) 2011; 106 Cox (10.1016/j.cjca.2016.07.591_bib92) 1999; 118 Beyer-Westendorf (10.1016/j.cjca.2016.07.591_bib78) 2014; 35 Verma (10.1016/j.cjca.2016.07.591_bib111) 2015; 15 Dentali (10.1016/j.cjca.2016.07.591_bib22) 2012; 126 Eikelboom (10.1016/j.cjca.2016.07.591_bib60) 2015; 132 Cairns (10.1016/j.cjca.2016.07.591_bib13) 1998; 114 Gillinov (10.1016/j.cjca.2016.07.591_bib88) 2015; 372 Trivedi (10.1016/j.cjca.2016.07.591_bib110) 2014; 46 Tamayo (10.1016/j.cjca.2016.07.591_bib48) 2015; 38 David (10.1016/j.cjca.2016.07.591_bib80) 1979; 44 Glund (10.1016/j.cjca.2016.07.591_bib63) 2015; 386 Patel (10.1016/j.cjca.2016.07.591_bib24) 2011; 365 Mozaffarian (10.1016/j.cjca.2016.07.591_bib109) 2012; 308 Smith (10.1016/j.cjca.2016.07.591_bib14) 1990; 323 Avgil Tsadok (10.1016/j.cjca.2016.07.591_bib50) 2015; 8 Bando (10.1016/j.cjca.2016.07.591_bib89) 2002; 124 Whitlock (10.1016/j.cjca.2016.07.591_bib104) 2008; 29 Costanzo (10.1016/j.cjca.2016.07.591_bib108) 2013; 146 Fiore (10.1016/j.cjca.2016.07.591_bib16) 2002; 105 Tanguay (10.1016/j.cjca.2016.07.591_bib7) 2013; 29 Anand (10.1016/j.cjca.2016.07.591_bib17) 2003; 41 Siegal (10.1016/j.cjca.2016.07.591_bib71) 2012; 126 |
| References_xml | – volume: 30 start-page: 1317 year: 2014 end-page: 1325 ident: bib49 article-title: Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients publication-title: Curr Med Res Opin contributor: fullname: Nelson – volume: 46 start-page: 590 year: 2014 end-page: 595 ident: bib110 article-title: Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis publication-title: Indian J Pharmacol contributor: fullname: Sadadia – volume: 373 start-page: 511 year: 2015 end-page: 520 ident: bib64 article-title: Idarucizumab for dabigatran reversal publication-title: N Engl J Med contributor: fullname: Eikelboom – volume: 360 start-page: 2066 year: 2009 end-page: 2078 ident: bib40 article-title: Effect of clopidogrel added to aspirin in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: Pogue – volume: 372 start-page: 1399 year: 2015 end-page: 1409 ident: bib88 article-title: Surgical ablation of atrial fibrillation during mitral-valve surgery publication-title: N Engl J Med contributor: fullname: Parides – volume: 358 start-page: 527 year: 2001 end-page: 533 ident: bib36 article-title: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study publication-title: Lancet contributor: fullname: Peters – volume: 15 start-page: 18 year: 2015 ident: bib58 article-title: Bleeding complications from the direct oral anticoagulants publication-title: BMC Hematol contributor: fullname: Lin – volume: 365 start-page: 883 year: 2011 end-page: 891 ident: bib24 article-title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation publication-title: N Engl J Med contributor: fullname: Garg – volume: 371 start-page: 2155 year: 2014 end-page: 2166 ident: bib27 article-title: Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents publication-title: N Engl J Med contributor: fullname: Yeh – volume: 29 start-page: 1443 year: 2013 end-page: 1447 ident: bib97 article-title: Left Atrial Appendage Occlusion Study II (LAAOS II) publication-title: Can J Cardiol contributor: fullname: Blackall – volume: 131 start-page: 157 year: 2015 end-page: 164 ident: bib44 article-title: Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation publication-title: Circulation contributor: fullname: Wernecke – volume: 27 start-page: 91 year: 2011 end-page: 97 ident: bib100 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery publication-title: Can J Cardiol contributor: fullname: Mitchell – volume: 373 start-page: 823 year: 2015 end-page: 833 ident: bib72 article-title: Perioperative bridging anticoagulation in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: Kaatz – volume: 385 start-page: 2371 year: 2015 end-page: 2382 ident: bib29 article-title: Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials publication-title: Lancet contributor: fullname: Bacchi-Reggiani – volume: 118 start-page: 833 year: 1999 end-page: 840 ident: bib92 article-title: Impact of the maze procedure on the stroke rate in patients with atrial fibrillation publication-title: J Thorac Cardiovasc Surg contributor: fullname: Palazzo – volume: 65 start-page: 2211 year: 2015 end-page: 2221 ident: bib32 article-title: Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction publication-title: J Am Coll Cardiol contributor: fullname: Steg – volume: 361 start-page: 1045 year: 2009 end-page: 1057 ident: bib38 article-title: Ticagrelor versus clopidogrel in patients with acute coronary syndromes publication-title: N Engl J Med contributor: fullname: Budaj – volume: 44 start-page: 1378 year: 1979 end-page: 1382 ident: bib80 article-title: Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent publication-title: Am J Cardiol contributor: fullname: Kaplinsky – volume: 100 start-page: 722 year: 2014 end-page: 730 ident: bib86 article-title: Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials publication-title: Heart contributor: fullname: Yan – volume: 374 start-page: 1744 year: 2016 end-page: 1753 ident: bib103 article-title: Perioperative rosuvastatin in cardiac surgery publication-title: N Engl J Med contributor: fullname: Jiang – volume: 323 start-page: 147 year: 1990 end-page: 152 ident: bib14 article-title: The effect of warfarin on mortality and reinfarction after myocardial infarction publication-title: N Engl J Med contributor: fullname: Holme – volume: 173 start-page: 102 year: 2016 end-page: 107 ident: bib70 article-title: Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: the BRUISE CONTROL-2 trial publication-title: Am Heart J contributor: fullname: Ayala-Paredes – volume: 113 start-page: 943 year: 2015 end-page: 951 ident: bib62 article-title: A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran publication-title: Thromb Haemost contributor: fullname: Norris – volume: 28 start-page: 125 year: 2012 end-page: 136 ident: bib2 article-title: Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control publication-title: Can J Cardiol contributor: fullname: Cairns – volume: 374 start-page: 534 year: 2009 end-page: 542 ident: bib94 article-title: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial publication-title: Lancet contributor: fullname: Turi – volume: 15 start-page: 96 year: 2015 ident: bib111 article-title: Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials publication-title: BMC Cardiovasc Disord contributor: fullname: Nidorf – volume: 369 start-page: 2093 year: 2013 end-page: 2104 ident: bib25 article-title: Edoxaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: Braunwald – volume: 35 start-page: 3155 year: 2014 end-page: 3179 ident: bib9 article-title: Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) publication-title: Eur Heart J contributor: fullname: Huber – volume: 132 start-page: 2412 year: 2015 end-page: 2422 ident: bib60 article-title: Idarucizumab: the antidote for reversal of dabigatran publication-title: Circulation contributor: fullname: Weitz – volume: 31 start-page: 1207 year: 2015 end-page: 1218 ident: bib5 article-title: The 2014 atrial fibrillation guidelines companion: a practical approach to the use of the Canadian Cardiovascular Society guidelines publication-title: Can J Cardiol contributor: fullname: Andrade – volume: 129 start-page: 1850 year: 2014 end-page: 1859 ident: bib74 article-title: Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF) publication-title: Circulation contributor: fullname: Patel – volume: 372 start-page: 1791 year: 2015 end-page: 1800 ident: bib39 article-title: Long-term use of ticagrelor in patients with prior myocardial infarction publication-title: N Engl J Med contributor: fullname: Cohen – volume: 15 start-page: 625 year: 2013 end-page: 651 ident: bib53 article-title: European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation publication-title: Europace contributor: fullname: Alings – volume: 106 start-page: 572 year: 2011 end-page: 584 ident: bib11 article-title: Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North American perspective publication-title: Thromb Haemost contributor: fullname: Berger – volume: 141 start-page: e326S year: 2012 end-page: e350 ident: bib67 article-title: Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines publication-title: Chest contributor: fullname: Spencer – volume: 1 start-page: CD003611 year: 2013 ident: bib102 article-title: Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery publication-title: Cochrane Database Syst Rev contributor: fullname: Crystal – volume: 383 start-page: 955 year: 2014 end-page: 962 ident: bib26 article-title: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials publication-title: Lancet contributor: fullname: Braunwald – volume: 373 start-page: 2413 year: 2015 end-page: 2424 ident: bib59 article-title: Andexanet Alfa for the reversal of factor Xa inhibitor activity publication-title: N Engl J Med contributor: fullname: Connolly – volume: 27 start-page: 27 year: 2011 end-page: 30 ident: bib1 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: implementing GRADE and achieving consensus publication-title: Can J Cardiol contributor: fullname: Skanes – volume: 43 start-page: 1812 year: 2012 end-page: 1817 ident: bib51 article-title: Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal publication-title: Stroke contributor: fullname: Asdaghi – volume: 115 start-page: 1185 year: 2015 end-page: 1193 ident: bib34 article-title: Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention publication-title: Am J Cardiol contributor: fullname: Moretti – volume: 17 start-page: 1467 year: 2015 end-page: 1507 ident: bib10 article-title: Updated European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation publication-title: Europace contributor: fullname: Alings – volume: 3 start-page: 45 year: 2014 end-page: 54 ident: bib98 article-title: Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III publication-title: Ann Cardiothorac Surg contributor: fullname: Vincent – volume: 126 start-page: 1630 year: 2012 end-page: 1639 ident: bib71 article-title: Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates publication-title: Circulation contributor: fullname: Kaatz – volume: 65 start-page: 805 year: 2015 end-page: 815 ident: bib31 article-title: Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates publication-title: J Am Coll Cardiol contributor: fullname: Thury – volume: 29 start-page: 1334 year: 2013 end-page: 1345 ident: bib7 article-title: Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy publication-title: Can J Cardiol contributor: fullname: Ackman – volume: 8 start-page: 593 year: 2015 end-page: 599 ident: bib50 article-title: Sex differences in dabigatran use, safety, and effectiveness in a population-based cohort of patients with atrial fibrillation publication-title: Circ Cardiovasc Qual Outcomes contributor: fullname: Pilote – volume: 349 start-page: g6427 year: 2014 ident: bib30 article-title: Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis publication-title: BMJ contributor: fullname: Kaiser – volume: 29 start-page: 1030 year: 2006 end-page: 1035 ident: bib91 article-title: The impact of mitral valve surgery combined with maze procedure publication-title: Eur J Cardiothorac Surg contributor: fullname: Bando – volume: 374 start-page: 1911 year: 2016 end-page: 1921 ident: bib101 article-title: Rate control versus rhythm control for atrial fibrillation after cardiac surgery publication-title: N Engl J Med contributor: fullname: Moskowitz – volume: 132 start-page: 167 year: 2015 end-page: 173 ident: bib77 article-title: Perioperative management of dabigatran: a prospective cohort study publication-title: Circulation contributor: fullname: Lee – volume: 4 year: 2015 ident: bib47 article-title: Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study publication-title: J Am Heart Assoc contributor: fullname: Gehi – volume: 126 start-page: 2381 year: 2012 end-page: 2391 ident: bib22 article-title: Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature publication-title: Circulation contributor: fullname: Crowther – volume: 105 start-page: 557 year: 2002 end-page: 563 ident: bib16 article-title: Department of Veterans Affairs Cooperative Studies Program clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study publication-title: Circulation contributor: fullname: Brophy – volume: 115 start-page: 152 year: 2016 end-page: 160 ident: bib46 article-title: Dabigatran use in elderly patients with atrial fibrillation publication-title: Thromb Haemost contributor: fullname: Essebag – volume: 2 year: 2012 ident: bib21 article-title: Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials publication-title: BMJ Open contributor: fullname: Mak – volume: 151 start-page: 297 year: 2009 end-page: 305 ident: bib8 article-title: The net clinical benefit of warfarin anticoagulation in atrial fibrillation publication-title: Ann Intern Med contributor: fullname: Fang – volume: 114 start-page: 401 year: 2014 end-page: 406 ident: bib83 article-title: Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure publication-title: Am J Cardiol contributor: fullname: Jackevicius – volume: 126 start-page: 343 year: 2012 end-page: 348 ident: bib73 article-title: Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial publication-title: Circulation contributor: fullname: Douketis – volume: 114 start-page: 611S year: 1998 end-page: 633S ident: bib13 article-title: Antithrombotic agents in coronary artery disease publication-title: Chest contributor: fullname: Lewis – volume: 365 start-page: 981 year: 2011 end-page: 992 ident: bib23 article-title: Apixaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: McMurray – volume: 336 start-page: 1506 year: 1997 end-page: 1511 ident: bib66 article-title: Management of anticoagulation before and after elective surgery publication-title: N Engl J Med contributor: fullname: Hirsh – volume: 27 start-page: S1 year: 2011 end-page: S59 ident: bib6 article-title: The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines publication-title: Can J Cardiol contributor: fullname: Cartier – volume: 381 start-page: 1107 year: 2013 end-page: 1115 ident: bib35 article-title: Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial publication-title: Lancet contributor: fullname: Verheugt – volume: 103 start-page: 1116 year: 2010 end-page: 1127 ident: bib65 article-title: Dabigatran etexilate–a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity publication-title: Thromb Haemost contributor: fullname: Haertter – volume: 29 start-page: 2592 year: 2008 end-page: 2600 ident: bib104 article-title: Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials publication-title: Eur Heart J contributor: fullname: Devereaux – volume: 35 start-page: 1888 year: 2014 end-page: 1896 ident: bib78 article-title: Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry publication-title: Eur Heart J contributor: fullname: Forster – volume: 41 start-page: 62S year: 2003 end-page: 69S ident: bib17 article-title: Oral anticoagulants in patients with coronary artery disease publication-title: J Am Coll Cardiol contributor: fullname: Yusuf – volume: 347 start-page: 969 year: 2002 end-page: 974 ident: bib15 article-title: Warfarin, aspirin, or both after myocardial infarction publication-title: N Engl J Med contributor: fullname: Arnesen – volume: 38 start-page: 63 year: 2015 end-page: 68 ident: bib48 article-title: Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban publication-title: Clin Cardiol contributor: fullname: Patel – volume: 64 start-page: 1 year: 2014 end-page: 12 ident: bib95 article-title: Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial publication-title: J Am Coll Cardiol contributor: fullname: Price – volume: 146 start-page: 906 year: 2013 end-page: 911 ident: bib108 article-title: Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis publication-title: J Thorac Cardiovasc Surg contributor: fullname: Di Castelnuovo – volume: 27 start-page: 47 year: 2011 end-page: 59 ident: bib85 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management publication-title: Can J Cardiol contributor: fullname: Talajic – volume: 308 start-page: 1761 year: 2012 end-page: 1767 ident: bib105 article-title: Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial publication-title: JAMA contributor: fullname: Rosseel – volume: 33 start-page: 304 year: 1999 end-page: 310 ident: bib79 article-title: Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens publication-title: J Am Coll Cardiol contributor: fullname: Singh – volume: 141 start-page: e531S year: 2012 end-page: e575 ident: bib18 article-title: Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest contributor: fullname: Howard – volume: 385 start-page: 2363 year: 2015 end-page: 2370 ident: bib82 article-title: Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) publication-title: Lancet contributor: fullname: Lokhnygina – volume: 66 start-page: 616 year: 2015 end-page: 627 ident: bib33 article-title: Use and outcomes of triple therapy among older patients with acute myocardial infarction and atrial fibrillation publication-title: J Am Coll Cardiol contributor: fullname: Peng – volume: 61 start-page: 755 year: 1996 end-page: 759 ident: bib93 article-title: Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation publication-title: Ann Thorac Surg contributor: fullname: Odell – volume: 350 start-page: h1618 year: 2015 ident: bib28 article-title: Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials publication-title: BMJ contributor: fullname: Schulze – volume: 63 start-page: 53 year: 2014 end-page: 59 ident: bib107 article-title: Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials publication-title: J Cardiol contributor: fullname: Zhang – volume: 65 start-page: 1320 year: 2008 end-page: 1325 ident: bib52 article-title: Predictors of outcome in warfarin-related intracerebral hemorrhage publication-title: Arch Neurol contributor: fullname: Claassen – volume: 13 start-page: S187 year: 2015 end-page: S194 ident: bib56 article-title: Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re-appraisal publication-title: J Thromb Haemost contributor: fullname: Dzik – volume: 368 start-page: 2084 year: 2013 end-page: 2093 ident: bib69 article-title: Pacemaker or defibrillator surgery without interruption of anticoagulation publication-title: N Engl J Med contributor: fullname: Wells – volume: 30 start-page: 1114 year: 2014 end-page: 1130 ident: bib3 article-title: 2014 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation publication-title: Can J Cardiol contributor: fullname: Mitchell – volume: 27 start-page: 67 year: 2011 end-page: 73 ident: bib99 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: surgical therapy publication-title: Can J Cardiol contributor: fullname: Page – volume: 127 start-page: 634 year: 2013 end-page: 640 ident: bib41 article-title: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial publication-title: Circulation contributor: fullname: Wallentin – volume: 106 start-page: 429 year: 2011 end-page: 438 ident: bib57 article-title: Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. a meta-analysis publication-title: Thromb Haemost contributor: fullname: Giorgi Pierfranceschi – volume: 124 start-page: 3692 year: 2014 end-page: 3698 ident: bib75 article-title: Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures publication-title: Blood contributor: fullname: Wallentin – volume: 366 start-page: 9 year: 2012 end-page: 19 ident: bib43 article-title: Rivaroxaban in patients with a recent acute coronary syndrome publication-title: N Engl J Med contributor: fullname: Wiviott – volume: 125 start-page: 669 year: 2012 end-page: 676 ident: bib20 article-title: Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial publication-title: Circulation contributor: fullname: Yang – volume: 386 start-page: 1243 year: 2015 end-page: 1253 ident: bib106 article-title: Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial publication-title: Lancet contributor: fullname: Teoh – volume: 41 start-page: 253 year: 2016 end-page: 272 ident: bib55 article-title: Who, when, and how to reverse non-vitamin K oral anticoagulants publication-title: J Thromb Thrombolysis contributor: fullname: Hylek – volume: 13 start-page: 54 year: 2016 end-page: 61 ident: bib84 article-title: Heart rate and adverse outcomes in patients with atrial fibrillation: a combined AFFIRM and AF-CHF substudy publication-title: Heart Rhythm contributor: fullname: Wyse – volume: 386 start-page: 680 year: 2015 end-page: 690 ident: bib63 article-title: Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial publication-title: Lancet contributor: fullname: Schmohl – volume: 29 start-page: S60 year: 2013 end-page: S70 ident: bib12 article-title: Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease publication-title: Can J Cardiol contributor: fullname: McMurtry – volume: 64 start-page: 660 year: 2014 end-page: 668 ident: bib81 article-title: Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study publication-title: J Am Coll Cardiol contributor: fullname: Winkelmayer – volume: 27 start-page: 74 year: 2011 end-page: 90 ident: bib4 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter publication-title: Can J Cardiol contributor: fullname: McMurtry – volume: 361 start-page: 1139 year: 2009 end-page: 1151 ident: bib19 article-title: Dabigatran versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med contributor: fullname: Yusuf – volume: 65 start-page: 1619 year: 2015 end-page: 1629 ident: bib42 article-title: Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial publication-title: J Am Coll Cardiol contributor: fullname: Mehilli – volume: 124 start-page: 575 year: 2002 end-page: 583 ident: bib89 article-title: Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease publication-title: J Thorac Cardiovasc Surg contributor: fullname: Kosakai – volume: 20 start-page: 200 year: 2015 ident: bib76 article-title: Interruption of all anticoagulation is non-inferior to the use of short-term parenteral bridging in patients with atrial fibrillation undergoing invasive procedures publication-title: Evid Based Med contributor: fullname: Steinberg – volume: 33 start-page: 2644 year: 2012 end-page: 2652 ident: bib87 article-title: Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study publication-title: Eur Heart J contributor: fullname: Osmancik – volume: 126 start-page: 358 year: 2003 end-page: 364 ident: bib90 article-title: Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience publication-title: J Thorac Cardiovasc Surg contributor: fullname: Hirata – volume: 308 start-page: 2001 year: 2012 end-page: 2011 ident: bib109 article-title: Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial publication-title: JAMA contributor: fullname: Macchia – volume: 357 start-page: 2001 year: 2007 end-page: 2015 ident: bib37 article-title: Prasugrel versus clopidogrel in patients with acute coronary syndromes publication-title: N Engl J Med contributor: fullname: McCabe – volume: 65 start-page: 2614 year: 2015 end-page: 2623 ident: bib96 article-title: Left Atrial Appendage Closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis publication-title: J Am Coll Cardiol contributor: fullname: Kar – volume: 308 start-page: 1761 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib105 article-title: Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.2012.14144 contributor: fullname: Dieleman – volume: 141 start-page: e326S year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib67 article-title: Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines publication-title: Chest doi: 10.1378/chest.11-2298 contributor: fullname: Douketis – volume: 127 start-page: 634 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib41 article-title: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.115386 contributor: fullname: Dans – volume: 65 start-page: 2211 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib32 article-title: Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.03.003 contributor: fullname: Yeh – volume: 46 start-page: 590 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib110 article-title: Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis publication-title: Indian J Pharmacol doi: 10.4103/0253-7613.144905 contributor: fullname: Trivedi – volume: 115 start-page: 1185 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib34 article-title: Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2015.02.003 contributor: fullname: D'Ascenzo – volume: 369 start-page: 2093 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib25 article-title: Edoxaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1310907 contributor: fullname: Giugliano – volume: 386 start-page: 1243 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib106 article-title: Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(15)00273-1 contributor: fullname: Whitlock – volume: 28 start-page: 125 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib2 article-title: Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control publication-title: Can J Cardiol doi: 10.1016/j.cjca.2012.01.021 contributor: fullname: Skanes – volume: 63 start-page: 53 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib107 article-title: Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials publication-title: J Cardiol contributor: fullname: Zhang – volume: 29 start-page: 1334 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib7 article-title: Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy publication-title: Can J Cardiol doi: 10.1016/j.cjca.2013.07.001 contributor: fullname: Tanguay – volume: 61 start-page: 755 year: 1996 ident: 10.1016/j.cjca.2016.07.591_bib93 article-title: Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation publication-title: Ann Thorac Surg doi: 10.1016/0003-4975(95)00887-X contributor: fullname: Blackshear – volume: 365 start-page: 883 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib24 article-title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1009638 contributor: fullname: Patel – ident: 10.1016/j.cjca.2016.07.591_bib54 – volume: 374 start-page: 534 year: 2009 ident: 10.1016/j.cjca.2016.07.591_bib94 article-title: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial publication-title: Lancet doi: 10.1016/S0140-6736(09)61343-X contributor: fullname: Holmes – volume: 13 start-page: 54 year: 2016 ident: 10.1016/j.cjca.2016.07.591_bib84 article-title: Heart rate and adverse outcomes in patients with atrial fibrillation: a combined AFFIRM and AF-CHF substudy publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2015.08.028 contributor: fullname: Andrade – volume: 20 start-page: 200 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib76 article-title: Interruption of all anticoagulation is non-inferior to the use of short-term parenteral bridging in patients with atrial fibrillation undergoing invasive procedures publication-title: Evid Based Med doi: 10.1136/ebmed-2015-110263 contributor: fullname: Steinberg – volume: 41 start-page: 62S year: 2003 ident: 10.1016/j.cjca.2016.07.591_bib17 article-title: Oral anticoagulants in patients with coronary artery disease publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)02776-6 contributor: fullname: Anand – volume: 373 start-page: 823 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib72 article-title: Perioperative bridging anticoagulation in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1501035 contributor: fullname: Douketis – volume: 132 start-page: 167 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib77 article-title: Perioperative management of dabigatran: a prospective cohort study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.015688 contributor: fullname: Schulman – volume: 29 start-page: 2592 year: 2008 ident: 10.1016/j.cjca.2016.07.591_bib104 article-title: Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials publication-title: Eur Heart J doi: 10.1093/eurheartj/ehn333 contributor: fullname: Whitlock – volume: 113 start-page: 943 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib62 article-title: A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran publication-title: Thromb Haemost doi: 10.1160/TH14-12-1080 contributor: fullname: Glund – volume: 44 start-page: 1378 year: 1979 ident: 10.1016/j.cjca.2016.07.591_bib80 article-title: Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent publication-title: Am J Cardiol doi: 10.1016/0002-9149(79)90456-9 contributor: fullname: David – ident: 10.1016/j.cjca.2016.07.591_bib68 – volume: 65 start-page: 2614 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib96 article-title: Left Atrial Appendage Closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.04.025 contributor: fullname: Holmes – volume: 15 start-page: 18 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib58 article-title: Bleeding complications from the direct oral anticoagulants publication-title: BMC Hematol doi: 10.1186/s12878-015-0039-z contributor: fullname: Sholzberg – volume: 27 start-page: 67 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib99 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: surgical therapy publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.008 contributor: fullname: Page – volume: 357 start-page: 2001 year: 2007 ident: 10.1016/j.cjca.2016.07.591_bib37 article-title: Prasugrel versus clopidogrel in patients with acute coronary syndromes publication-title: N Engl J Med doi: 10.1056/NEJMoa0706482 contributor: fullname: Wiviott – volume: 124 start-page: 575 year: 2002 ident: 10.1016/j.cjca.2016.07.591_bib89 article-title: Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease publication-title: J Thorac Cardiovasc Surg doi: 10.1067/mtc.2002.124392 contributor: fullname: Bando – volume: 173 start-page: 102 year: 2016 ident: 10.1016/j.cjca.2016.07.591_bib70 article-title: Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: the BRUISE CONTROL-2 trial publication-title: Am Heart J doi: 10.1016/j.ahj.2015.12.007 contributor: fullname: Essebag – volume: 65 start-page: 1619 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib42 article-title: Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.02.050 contributor: fullname: Fiedler – volume: 8 start-page: 593 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib50 article-title: Sex differences in dabigatran use, safety, and effectiveness in a population-based cohort of patients with atrial fibrillation publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.114.001398 contributor: fullname: Avgil Tsadok – volume: 368 start-page: 2084 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib69 article-title: Pacemaker or defibrillator surgery without interruption of anticoagulation publication-title: N Engl J Med doi: 10.1056/NEJMoa1302946 contributor: fullname: Birnie – volume: 65 start-page: 1320 year: 2008 ident: 10.1016/j.cjca.2016.07.591_bib52 article-title: Predictors of outcome in warfarin-related intracerebral hemorrhage publication-title: Arch Neurol doi: 10.1001/archneur.65.10.1320 contributor: fullname: Zubkov – volume: 43 start-page: 1812 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib51 article-title: Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal publication-title: Stroke doi: 10.1161/STROKEAHA.112.652065 contributor: fullname: Dowlatshahi – volume: 31 start-page: 1207 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib5 article-title: The 2014 atrial fibrillation guidelines companion: a practical approach to the use of the Canadian Cardiovascular Society guidelines publication-title: Can J Cardiol doi: 10.1016/j.cjca.2015.06.005 contributor: fullname: Macle – volume: 29 start-page: S60 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib12 article-title: Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease publication-title: Can J Cardiol doi: 10.1016/j.cjca.2013.04.006 contributor: fullname: Cairns – volume: 103 start-page: 1116 year: 2010 ident: 10.1016/j.cjca.2016.07.591_bib65 article-title: Dabigatran etexilate–a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity publication-title: Thromb Haemost doi: 10.1160/TH09-11-0758 contributor: fullname: van Ryn – volume: 27 start-page: S1 issue: suppl A year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib6 article-title: The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.12.015 contributor: fullname: Bell – volume: 106 start-page: 572 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib11 article-title: Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North American perspective publication-title: Thromb Haemost doi: 10.1160/TH11-04-0262 contributor: fullname: Faxon – volume: 385 start-page: 2363 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib82 publication-title: Lancet doi: 10.1016/S0140-6736(14)61836-5 contributor: fullname: Washam – volume: 125 start-page: 669 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib20 article-title: Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.055970 contributor: fullname: Hohnloser – volume: 29 start-page: 1030 year: 2006 ident: 10.1016/j.cjca.2016.07.591_bib91 article-title: The impact of mitral valve surgery combined with maze procedure publication-title: Eur J Cardiothorac Surg doi: 10.1016/j.ejcts.2006.03.028 contributor: fullname: Itoh – volume: 100 start-page: 722 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib86 article-title: Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials publication-title: Heart doi: 10.1136/heartjnl-2013-305351 contributor: fullname: Phan – volume: 374 start-page: 1744 year: 2016 ident: 10.1016/j.cjca.2016.07.591_bib103 article-title: Perioperative rosuvastatin in cardiac surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1507750 contributor: fullname: Zheng – volume: 385 start-page: 2371 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib29 article-title: Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(15)60263-X contributor: fullname: Palmerini – volume: 371 start-page: 2155 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib27 article-title: Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents publication-title: N Engl J Med doi: 10.1056/NEJMoa1409312 contributor: fullname: Mauri – volume: 65 start-page: 805 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib31 article-title: Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.11.053 contributor: fullname: Valgimigli – volume: 15 start-page: 625 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib53 article-title: European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation publication-title: Europace doi: 10.1093/europace/eut083 contributor: fullname: Heidbuchel – volume: 381 start-page: 1107 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib35 article-title: Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(12)62177-1 contributor: fullname: Dewilde – volume: 33 start-page: 304 year: 1999 ident: 10.1016/j.cjca.2016.07.591_bib79 article-title: Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(98)00561-0 contributor: fullname: Farshi – volume: 27 start-page: 74 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib4 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.007 contributor: fullname: Cairns – volume: 386 start-page: 680 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib63 article-title: Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial publication-title: Lancet doi: 10.1016/S0140-6736(15)60732-2 contributor: fullname: Glund – volume: 373 start-page: 2413 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib59 article-title: Andexanet Alfa for the reversal of factor Xa inhibitor activity publication-title: N Engl J Med doi: 10.1056/NEJMoa1510991 contributor: fullname: Siegal – volume: 114 start-page: 611S year: 1998 ident: 10.1016/j.cjca.2016.07.591_bib13 article-title: Antithrombotic agents in coronary artery disease publication-title: Chest doi: 10.1378/chest.114.5_Supplement.611S contributor: fullname: Cairns – volume: 365 start-page: 981 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib23 article-title: Apixaban versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1107039 contributor: fullname: Granger – volume: 29 start-page: 1443 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib97 article-title: Left Atrial Appendage Occlusion Study II (LAAOS II) publication-title: Can J Cardiol doi: 10.1016/j.cjca.2013.06.015 contributor: fullname: Whitlock – volume: 126 start-page: 343 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib73 article-title: Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.090464 contributor: fullname: Healey – volume: 30 start-page: 1317 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib49 article-title: Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients publication-title: Curr Med Res Opin doi: 10.1185/03007995.2014.907140 contributor: fullname: Laliberte – volume: 4 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib47 article-title: Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study publication-title: J Am Heart Assoc contributor: fullname: Lauffenburger – volume: 114 start-page: 401 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib83 article-title: Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2014.05.013 contributor: fullname: Shah – volume: 141 start-page: e531S year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib18 article-title: Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest doi: 10.1378/chest.11-2304 contributor: fullname: You – volume: 349 start-page: g6427 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib30 article-title: Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis publication-title: BMJ doi: 10.1136/bmj.g6427 contributor: fullname: Valgimigli – volume: 126 start-page: 1630 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib71 article-title: Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.105221 contributor: fullname: Siegal – volume: 17 start-page: 1467 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib10 article-title: Updated European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation publication-title: Europace doi: 10.1093/europace/euv309 contributor: fullname: Heidbuchel – ident: 10.1016/j.cjca.2016.07.591_bib61 – volume: 15 start-page: 96 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib111 article-title: Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-015-0068-3 contributor: fullname: Verma – volume: 27 start-page: 27 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib1 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: implementing GRADE and achieving consensus publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.003 contributor: fullname: Gillis – volume: 33 start-page: 2644 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib87 article-title: Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs290 contributor: fullname: Budera – volume: 35 start-page: 1888 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib78 article-title: Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry publication-title: Eur Heart J doi: 10.1093/eurheartj/eht557 contributor: fullname: Beyer-Westendorf – volume: 366 start-page: 9 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib43 article-title: Rivaroxaban in patients with a recent acute coronary syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa1112277 contributor: fullname: Mega – volume: 105 start-page: 557 year: 2002 ident: 10.1016/j.cjca.2016.07.591_bib16 article-title: Department of Veterans Affairs Cooperative Studies Program clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study publication-title: Circulation doi: 10.1161/hc0502.103329 contributor: fullname: Fiore – volume: 374 start-page: 1911 year: 2016 ident: 10.1016/j.cjca.2016.07.591_bib101 article-title: Rate control versus rhythm control for atrial fibrillation after cardiac surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1602002 contributor: fullname: Gillinov – volume: 3 start-page: 45 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib98 article-title: Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III publication-title: Ann Cardiothorac Surg contributor: fullname: Whitlock – volume: 66 start-page: 616 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib33 article-title: Use and outcomes of triple therapy among older patients with acute myocardial infarction and atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.05.062 contributor: fullname: Hess – volume: 106 start-page: 429 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib57 article-title: Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. a meta-analysis publication-title: Thromb Haemost doi: 10.1160/TH11-01-0052 contributor: fullname: Dentali – volume: 347 start-page: 969 year: 2002 ident: 10.1016/j.cjca.2016.07.591_bib15 article-title: Warfarin, aspirin, or both after myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa020496 contributor: fullname: Hurlen – volume: 38 start-page: 63 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib48 article-title: Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban publication-title: Clin Cardiol doi: 10.1002/clc.22373 contributor: fullname: Tamayo – volume: 2 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib21 article-title: Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials publication-title: BMJ Open doi: 10.1136/bmjopen-2012-001592 contributor: fullname: Mak – volume: 323 start-page: 147 year: 1990 ident: 10.1016/j.cjca.2016.07.591_bib14 article-title: The effect of warfarin on mortality and reinfarction after myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJM199007193230302 contributor: fullname: Smith – volume: 373 start-page: 511 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib64 article-title: Idarucizumab for dabigatran reversal publication-title: N Engl J Med doi: 10.1056/NEJMoa1502000 contributor: fullname: Pollack – volume: 372 start-page: 1791 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib39 article-title: Long-term use of ticagrelor in patients with prior myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa1500857 contributor: fullname: Bonaca – volume: 27 start-page: 91 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib100 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.005 contributor: fullname: Mitchell – volume: 30 start-page: 1114 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib3 article-title: 2014 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation publication-title: Can J Cardiol doi: 10.1016/j.cjca.2014.08.001 contributor: fullname: Verma – volume: 124 start-page: 3692 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib75 article-title: Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures publication-title: Blood doi: 10.1182/blood-2014-08-595496 contributor: fullname: Garcia – volume: 35 start-page: 3155 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib9 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu298 contributor: fullname: Lip – volume: 131 start-page: 157 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib44 article-title: Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.012061 contributor: fullname: Graham – volume: 361 start-page: 1139 year: 2009 ident: 10.1016/j.cjca.2016.07.591_bib19 article-title: Dabigatran versus warfarin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa0905561 contributor: fullname: Connolly – volume: 27 start-page: 47 year: 2011 ident: 10.1016/j.cjca.2016.07.591_bib85 article-title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.001 contributor: fullname: Gillis – volume: 1 start-page: CD003611 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib102 article-title: Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery publication-title: Cochrane Database Syst Rev contributor: fullname: Arsenault – volume: 64 start-page: 1 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib95 article-title: Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.04.029 contributor: fullname: Holmes – volume: 358 start-page: 527 year: 2001 ident: 10.1016/j.cjca.2016.07.591_bib36 article-title: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study publication-title: Lancet doi: 10.1016/S0140-6736(01)05701-4 contributor: fullname: Mehta – volume: 361 start-page: 1045 year: 2009 ident: 10.1016/j.cjca.2016.07.591_bib38 article-title: Ticagrelor versus clopidogrel in patients with acute coronary syndromes publication-title: N Engl J Med doi: 10.1056/NEJMoa0904327 contributor: fullname: Wallentin – volume: 126 start-page: 2381 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib22 article-title: Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.115410 contributor: fullname: Dentali – volume: 132 start-page: 2412 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib60 article-title: Idarucizumab: the antidote for reversal of dabigatran publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.019628 contributor: fullname: Eikelboom – volume: 372 start-page: 1399 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib88 article-title: Surgical ablation of atrial fibrillation during mitral-valve surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1500528 contributor: fullname: Gillinov – volume: 13 start-page: S187 issue: suppl 1 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib56 article-title: Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re-appraisal publication-title: J Thromb Haemost doi: 10.1111/jth.12949 contributor: fullname: Dzik – volume: 308 start-page: 2001 year: 2012 ident: 10.1016/j.cjca.2016.07.591_bib109 article-title: Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial publication-title: JAMA doi: 10.1001/jama.2012.28733 contributor: fullname: Mozaffarian – volume: 115 start-page: 152 year: 2016 ident: 10.1016/j.cjca.2016.07.591_bib46 article-title: Dabigatran use in elderly patients with atrial fibrillation publication-title: Thromb Haemost doi: 10.1160/TH15-03-0247 contributor: fullname: Avgil-Tsadok – volume: 118 start-page: 833 year: 1999 ident: 10.1016/j.cjca.2016.07.591_bib92 article-title: Impact of the maze procedure on the stroke rate in patients with atrial fibrillation publication-title: J Thorac Cardiovasc Surg doi: 10.1016/S0022-5223(99)70052-8 contributor: fullname: Cox – volume: 336 start-page: 1506 year: 1997 ident: 10.1016/j.cjca.2016.07.591_bib66 article-title: Management of anticoagulation before and after elective surgery publication-title: N Engl J Med doi: 10.1056/NEJM199705223362107 contributor: fullname: Kearon – volume: 146 start-page: 906 year: 2013 ident: 10.1016/j.cjca.2016.07.591_bib108 article-title: Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2013.03.015 contributor: fullname: Costanzo – volume: 151 start-page: 297 year: 2009 ident: 10.1016/j.cjca.2016.07.591_bib8 article-title: The net clinical benefit of warfarin anticoagulation in atrial fibrillation publication-title: Ann Intern Med doi: 10.7326/0003-4819-151-5-200909010-00003 contributor: fullname: Singer – volume: 126 start-page: 358 year: 2003 ident: 10.1016/j.cjca.2016.07.591_bib90 article-title: Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience publication-title: J Thorac Cardiovasc Surg doi: 10.1016/S0022-5223(03)00550-6 contributor: fullname: Bando – volume: 41 start-page: 253 year: 2016 ident: 10.1016/j.cjca.2016.07.591_bib55 article-title: Who, when, and how to reverse non-vitamin K oral anticoagulants publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-015-1297-0 contributor: fullname: Aronis – volume: 129 start-page: 1850 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib74 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.005754 contributor: fullname: Sherwood – volume: 64 start-page: 660 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib81 article-title: Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.03.060 contributor: fullname: Turakhia – ident: 10.1016/j.cjca.2016.07.591_bib45 – volume: 360 start-page: 2066 year: 2009 ident: 10.1016/j.cjca.2016.07.591_bib40 article-title: Effect of clopidogrel added to aspirin in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa0901301 contributor: fullname: The ACTIVE Investigators – volume: 350 start-page: h1618 year: 2015 ident: 10.1016/j.cjca.2016.07.591_bib28 article-title: Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials publication-title: BMJ doi: 10.1136/bmj.h1618 contributor: fullname: Navarese – volume: 383 start-page: 955 year: 2014 ident: 10.1016/j.cjca.2016.07.591_bib26 article-title: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(13)62343-0 contributor: fullname: Ruff |
| SSID | ssj0041776 |
| Score | 2.5960207 |
| SecondaryResourceType | review_article |
| Snippet | Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused... The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1170 |
| SubjectTerms | Acute Coronary Syndrome - therapy Algorithms Anticoagulants - therapeutic use Atrial Appendage - surgery Atrial Fibrillation - complications Atrial Fibrillation - therapy Cardiac Pacing, Artificial Cardiotonic Agents - administration & dosage Cardiotonic Agents - adverse effects Cardiovascular Catheter Ablation Coronary Artery Disease - complications Digoxin - administration & dosage Digoxin - adverse effects Drug Therapy, Combination Factor Xa Inhibitors - therapeutic use Fibrinolytic Agents - therapeutic use Hemorrhage - chemically induced Hemorrhage - prevention & control Humans Magnesium - therapeutic use Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - therapeutic use Postoperative Complications - prevention & control ST Elevation Myocardial Infarction - therapy Stroke - prevention & control |
| Title | 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0828282X16308297 https://dx.doi.org/10.1016/j.cjca.2016.07.591 https://www.ncbi.nlm.nih.gov/pubmed/27609430 https://search.proquest.com/docview/1835382750 |
| Volume | 32 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB5CCqGX0jZ9uI-gQG9la61Xa0lHY-o6bRJKW4NvYvWChOI1dXzNb8-MVus2hPQQ9rAPpNXu6PUJffMNwAfrNQ8JubmmKkTUtlCRRD-bGFWQETEq-TufnY_nC_F1WS_3YNr7whCtMo_93ZieRuv8ZJitOVxfXAx_kvgaHktEFMlBlDzYa05RDD5d72geopQpwBwlLih1dpzpOF7u0pH2UJkEPGtd3jc53Qc-0yQ0ewpPMnpkk-4Dn8FeWD2Hg7O8P34ILZXCZq3bboJnizUt51kbGaI81usQ4MW_FFSWeZvsy5YUr4gFzxDIpix_uTH0kkmK8MFm5CTwu6PQvYDF7POv6bzIIRUKR5ELCq9HTja2CpWz49IqH7jSNqEeJ1QjhPPeieijqLUWpWpkgxmd5ZIEjXGWewn7q3YVXgMT1gutKm4lLuG8s1rJMHI8BkQYQVg9gI-9Lc26U84wPaXs0pDlDdnEcGnQ8gOQvblN7xOKo1jY5C61MaXZjAw3d6p9APUu562WY3BS-G-Jx32tGuxStE_SrEK7xZIQlVaKhO8H8Kqr7t0fjOSYuJj8zQNLfQuP6a6jA76D_as_2_AeYc2VPUrt9ggeTaY_Tr_T-eTb_PwGqHT3qw |
| link.rule.ids | 314,780,784,4502,24116,27924,27925,45585,45679 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFH8CJgGXaRsf677wpN1QaNI4tX1EaF3HKJdRqTcr_pKKUFOt9Mrfvvccpxua4DDlEiV2XvLs-P0s_97PAF-MU7mPyM3WZcaDMpkMJPpZhyC9CIhRKd95cj0cT_nlrJptwUWXC0O0yjT2t2N6HK3TlX7yZn85n_d_kvgaHjNEFDFBdBte8ArRL3bqs4cNz4MXIu4wR6UzKp4yZ1qSl721JD5URAXPShVPRaen0GeMQqNX8DLBR3bevuFr2PKLN7A7SQvkB9CQFTZq7HrlHZsuaT7PmsAQ5rFOiABP_uagskTcZN_WJHlFNHiGSDZW-UOOoYecxy0-2IiyBO5aDt0hTEdfby7GWdpTIbO0dUHm1MCK2pS-tGZYGOl8LpWJsMdyWXNunbM8uMArpXgha1FjRWtyQYrGGOaOYGfRLPxbYNw4rmSZG4FzOGeNksIPbB48QgzPjerBaedLvWylM3THKbvV5HlNPtG50Oj5HojO3bpLCsVhzK_SP7XShV4NdK7_afceVJuaj7qOxqjwrMXPXatq_KdooaRe-GaNlhCWlpKU73tw3Db35gsGYkhkzPzdf1o9gb3xzeRKX32__vEe9ulOyw38ADv3v9b-I2Kce_Mp9uHfulf3sw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2016+Focused+Update+of+the+Canadian+Cardiovascular+Society+Guidelines+for+the+Management+of+Atrial+Fibrillation&rft.jtitle=Canadian+journal+of+cardiology&rft.au=Macle%2C+Laurent&rft.au=Cairns%2C+John&rft.au=Leblanc%2C+Kori&rft.au=Tsang%2C+Teresa&rft.date=2016-10-01&rft.pub=Elsevier+Inc&rft.issn=0828-282X&rft.eissn=1916-7075&rft.volume=32&rft.issue=10&rft.spage=1170&rft.epage=1185&rft_id=info:doi/10.1016%2Fj.cjca.2016.07.591&rft.externalDocID=S0828282X16308297 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0828-282X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0828-282X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0828-282X&client=summon |